Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.043
Neutral
RSI(14)
51.527
Neutral
STOCH(KDJ)(9,3,3)
73.187
Neutral
ATR(14)
0.227
High Vlolatility
CCI(14)
65.234
Neutral
Williams %R
30.324
Buy
TRIX(12,20)
-0.199
Sell
StochRSI(14)
0.000
Sell
Senestech Inc
SNES4.900USD
+0.020+0.41%
Market hours （ET）Quotes delayed by 15 min
18.44MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-09-04Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a good stock market performance and outperforming fundamentals, the technicals don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
1
analysts
Buy
Current Rating
10.000
Target Price
+104.08%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The Company's technology can also be applied to other mammalian species.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 82.24% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.86M.
Overvalued
The company’s latest PE is 0.09, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 110.88K shares, decreasing 33.84% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 13.50K shares of this stock.
Financial Health
Currency: USD Updated：2025-09-04The company's current financial score is 7.34, which is higher than the Chemicals industry's average of 6.99. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 485.00K, representing a year-over-year increase of 16.87%, while its net profit experienced a year-over-year increase of 9.12%.
Score
Financials
8.49
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.16
Operational Efficiency
6.80
Growth Potential
7.16
Shareholder Returns
7.07
Company Valuation
Currency: USD Updated：2025-09-04The company’s current valuation score is 4.80, which is higher than the Chemicals industry's average of 2.55. Its current P/E ratio is 0.09, which is -176.91% below the recent high of -0.07 and 1058.03% above the recent low of -0.82.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 54/72
No Data
Earnings Forecast
Currency: USD Updated：2025-09-04There is no earnings forecast score for this company; the Chemicals industry's average is 7.30. The average price target for Senestech Inc is 10.00, with a high of 10.00 and a low of 10.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
1
analysts
Buy
Current Rating
10.000
Target Price
+104.08%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
13
Total
4
Median
10
Average
Company name
Ratings
Analysts
Senestech Inc
SNES
1
Corteva Inc
CTVA
25
Nutrien Ltd
NTR
23
FMC Corp
FMC
21
CF Industries Holdings Inc
CF
20
Mosaic Co
MOS
19
1
2
3
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-09-04The company’s current price momentum score is 1.69, which is lower than the Chemicals industry's average of 8.17. Sideways: Currently, the stock price is trading between the resistance level at 5.88 and the support level at 3.94, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
4.916
Sell
MA10
4.781
Buy
MA20
4.744
Buy
MA50
4.941
Sell
MA100
3.804
Buy
MA200
3.259
Buy
Institutional Confidence
Currency: USD Updated：2025-09-04The company’s current institutional recognition score is 3.00, which is lower than the Chemicals industry's average of 7.92. The latest institutional shareholding proportion is 6.13%, representing a quarter-over-quarter increase of 1.93%. The largest institutional shareholder is The Vanguard, holding a total of 13.50K shares, representing 0.27% of shares outstanding, with 1.00% increase in holdings.
Score
Institutional Shareholding
No Data
Risk Assessment
Currency: USD Updated：2025-09-04The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Chemicals export-driven industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The company’s current risk assessment score is 3.11, which is lower than the Chemicals industry's average of 4.12. The company's beta value is 0.27. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.43
VaR
+10.52%
240-Day Maximum Drawdown
+66.75%
240-Day Volatility
+128.51%
Return
Best Daily Return
60 days
+30.94%
120 days
+30.94%
5 years
+101.12%
Worst Daily Return
60 days
-12.99%
120 days
-12.99%
5 years
-50.64%
Sharpe Ratio
60 days
+2.46
120 days
+1.88
5 years
-0.56
Risk Assessment
Maximum Drawdown
240 days
+66.75%
3 years
+99.84%
5 years
+99.98%
Return-to-Drawdown Ratio
240 days
+1.10
3 years
-0.33
5 years
-0.20
Skewness
240 days
+1.23
3 years
+2.26
5 years
+2.31
Volatility
Realised Volatility
240 days
+128.51%
5 years
+154.40%
Standardised True Range
240 days
+6.58%
5 years
+1977.61%
Downside Risk-Adjusted Return
120 days
+428.12%
240 days
+428.12%
Maximum Daily Upside Volatility
60 days
+117.62%
Maximum Daily Downside Volatility
60 days
+56.22%
Liquidity
Average Turnover Rate
60 days
+10.48%
120 days
+9.83%
5 years
--
Turnover Deviation
20 days
-99.34%
60 days
-99.12%
120 days
-99.18%
Peer Comparison
Currency: USD Updated：2025-09-04Senestech Inc
SNES
5.19 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Avient Corp
AVNT
7.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Axalta Coating Systems Ltd
AXTA
7.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Perimeter Solutions Inc
PRM
7.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Minerals Technologies Inc
MTX
7.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Corteva Inc
CTVA
7.30 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
